Year archive

Biomark Diagnostics Inc. — 2022 filings

All 19 regulatory filings released by Biomark Diagnostics Inc. (BUX) in 2022, sourced directly from the official regulator.

19 Filings

2022 Period

2022 filings (19)

Filing	Released	Lang
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2022-11-26	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2022-11-26	English
Interim MD&A - English.pdf Regulatory Filings	2022-11-26	English
Interim financial statements/report – English.pdf Regulatory Filings	2022-11-26	English
Letter from former auditor.pdf Regulatory Filings	2022-11-10	English
Letter from successor auditor.pdf Regulatory Filings	2022-11-10	English
Notice.pdf Regulatory Filings	2022-11-10	English
News release - English.pdf Regulatory Filings	2022-09-20	English
News release - English.pdf Regulatory Filings	2022-09-01	English
News release - English.pdf Regulatory Filings	2022-07-14	English
News release - English.pdf Regulatory Filings	2022-06-07	English
Report of exempt distribution excluding schedule 1 of Form 5.PDF Regulatory Filings	2022-05-10	English
Material change report - English.pdf Regulatory Filings	2022-05-04	English
News release - English.pdf Regulatory Filings	2022-05-04	English
News release - English.pdf Regulatory Filings	2022-04-27	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2022-02-28	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2022-02-28	English
Interim MD&A - English.pdf Regulatory Filings	2022-02-28	English
Interim financial statements/report – English.pdf Regulatory Filings	2022-02-28	English